Ozden Rabia Gurses
SEC insider (Form 3/4/5 filer). CIK 0001814883. Chief Medical Officer at Adverum Biotechnologies, Inc. (ADVM). 13 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in REDWOOD CITY, CA.
Companies Ozden Rabia Gurses has filed insider reports for
- Adverum Biotechnologies, Inc. (ADVM): Officer, Chief Medical Officer
Ozden Rabia Gurses
CIK: 0001814883
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Adverum Biotechnologies, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect8.1K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
AwardDirect85K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect85K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
8K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
4K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
85K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
44K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
48.8K shares- - Jun 17, 2025ADVM
Adverum Biotechnologies, Inc.
AwardDirectStock Option (Right to Buy)
4K shares- - Jun 17, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 8,125 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Award | 85,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 85,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 8,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 4,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 85,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 44,010 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 48,750 | - | - | Direct |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | Award Stock Option (Right to Buy) | 4,000 | - | - | Direct |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 8,000 | - | - | Direct |
1-10 of 13 transactions